Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma

NCT07428993 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Osteosarcoma

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Mesna
PROCEDURE: Apheresis
PROCEDURE: SJCARB7H3_41BBL infusion

Sponsor

St. Jude Children's Research Hospital